Research News for May 4, 2022
advertisement
- Congenital beta cell defects are not associated with markers of islet autoimmunity, even in the context of high genetic risk for type 1 diabetes
- Unveiling a novel type 1 diabetes endotype: Opportunities for intervention
- Identification of Novel Disease-Relevant Genes and Pathways in the Pathogenesis of Type 1 Diabetes: A Potential Defect in Pancreatic Iron Homeostasis
- Preclinical Models to Evaluate the Human Response to Autoantigen and Antigen-Specific Immunotherapy in Human Type 1 Diabetes (Full text HTML, PDF)
- Pancreas Whole Tissue Transcriptomics Highlights the Role of the Exocrine Pancreas in Patients With Recently Diagnosed Type 1 Diabetes (Full text HTML, PDF)
- Islet Encapsulation: New Developments for the Treatment of Type 1 Diabetes (Full text HTML, PDF)
- Propionate ameliorates diabetes-induced neurological dysfunction through regulating the PI3K/Akt/eNOS signaling pathway
- Prenatal and early life factors and type 1 diabetes (Full text HTML, PDF)
- Early exposures and inherent factors in premature newborns are associated with type 1 diabetes
- Evaluating T cell responses prior to the onset of type 1 diabetes
